Front Row Advisors LLC

SEC CIK: 0001729254
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

CRSP holding history

CRISPR Therapeutics AG in every 13F filed by Front Row Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRSP overview All 13F holders of CRSP Full Q2 2026 holdings

Shares (Q2 2026): 134
Value: $7.25K
% of portfolio: <0.1%
Quarters held: 22; Since Q1 2021

Holdings of CRSP by Front Row Advisors LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	134	$7.25K	<0.1%	00.0%	Unchanged	Holders
Q1 2026	134	$6.37K	<0.1%	00.0%	Unchanged	Holders
Q4 2025	134	$7.03K	<0.1%	00.0%	Unchanged	Holders
Q3 2025	134	$8.69K	<0.1%	+18+15.5%	Added	Holders
Q2 2025	116	$5.64K	<0.1%	00.0%	Unchanged	Holders
Q1 2025	116	$3.95K	<0.1%	00.0%	Unchanged	Holders
Q4 2024	116	$4.57K	<0.1%	00.0%	Unchanged	Holders
Q3 2024	116	$5.45K	<0.1%	00.0%	Unchanged	Holders
Q2 2024	116	$6.26K	<0.1%	00.0%	Unchanged	Holders
Q1 2024	116	$7.91K	<0.1%	00.0%	Unchanged	Holders
Q4 2023	116	$7.26K	<0.1%	−720−86.1%	Reduced	Holders
Q3 2023	836	$37.9K	<0.1%	−15,832−95.0%	Reduced	Holders
Q2 2023	16,668	$936.0K	0.4%	−600−3.5%	Reduced	Holders
Q1 2023	17,268	$781.0K	0.4%	−180−1.0%	Reduced	Holders
Q4 2022	17,448	$709.0K	0.4%	−1,405−7.5%	Reduced	Holders
Q3 2022	18,853	$1.23M	0.6%	−287−1.5%	Reduced	Holders
Q2 2022	19,140	$1.16M	0.6%	−20−0.1%	Reduced	Holders
Q1 2022	19,160	$1.20M	0.5%	+100+0.5%	Added	Holders
Q4 2021	19,060	$1.44M	0.5%	+1,294+7.3%	Added	Holders
Q3 2021	17,766	$1.99M	0.8%	+225+1.3%	Added	Holders
Q2 2021	17,541	$2.05M	0.8%	+1,043+6.3%	Added	Holders
Q1 2021	16,498	$2.01M	1.0%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.